CLAIM: Pfizer admits in its COVID-19 clinical trial protocol document that vaccinated people can âshedâ the vaccine, emitting materials that can spread to unvaccinated people by inhalation or skin contact.
THE FACTS: Pfizerâs COVID-19 vaccine does not shed from person to person, nor has the company admitted any such thing. âThe Pfizer-BioNTech COVID-19 vaccine is a synthetic mRNA vaccine and does not contain any virus particles. Because there is no virus produced in the body, no shedding occurs within the human body,â Pfizer spokesperson Jerica Pitts told The Associated Press in an email. âThe vaccine cannot be inhaled via shedding and can only enter the human body through an administered dose.â The U.S. Food and Drug Administration approved Pfizerâs vaccine in December after extensive clinical trials. Women who were pregnant or breastfeeding were excluded from joining those early clinical studies, and participants were instructed to take meas
New Jersey coronavirus update: Rutgers recruiting children for Pfizer s COVID-19 vaccine trial
Replay Video UP NEXT
A university in the Tri-State area has been selected as a clinical trial site for the global Pfizer-BioNTech COVID vaccine study in children.
Rutgers University, the only New Jersey site for the vaccine trial, will enroll as many as 200 kids ages 6 months to 11 years old in the study.
Rutgers will enroll 100 children ages 5 to 12 and 50 children each from the age groups 2 to 5 years and 6 months to 2 years out of 4,644 children worldwide.
This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.
Rutgers University
Rutgers, the only New Jersey site for the vaccine trial, will enroll as many as 200 children ages 6 months to 11 years as participants
Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years.
This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.
The Pediatric Clinical Research Center at Rutgers Robert Wood Johnson Medical School in New Brunswick is one of the several clinical trial sites for Pfizer-BioNTech’s pediatric study. It is the only clinical trial site in New Jersey. Rutgers will enroll up to 100 children ages 5 to 12 and 50 children each from the age groups 2 to 5 years and 6 months to 2 years out of 4,644 children to be enrolled worldwide.
UpdatedFri, May 7, 2021 at 1:25 pm ET
Replies(2)
(Shutterstock/FamVeld)
NEW BRUNSWICK, NJ Rutgers University announced Friday it has been selected as a clinical trial site for the Pfizer-BioNTech vaccine to be tested in children.
The Food & Drug Administration is expected to greenlight the Pfizer vaccine for older kids, ages 12-15, any day now. What Rutgers is involved in is a third Pfizer coronavirus vaccine trial, where the shot is currently being tested in children six months to under 12 years old.
Rutgers will test 200 children total in its trial. There will be 100 children in the 5-11 group, which will be tested first, followed by 50 children ages 2 to 5, and 50 children 6 months to 2 years.
E-Mail
The National Academies of Sciences, Engineering and Medicine has released a report that evaluated the state of primary care today to develop a plan to strengthen primary care services in the United States, especially in underserved communities.
The report, Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care, was written by a committee of experts including Shawna Hudson, professor and research division chief in the department of family medicine and community health at the Rutgers Robert Wood Johnson Medical School.
According to the report, ensuring access to high-quality primary care for all people in the United States will require reforming payment models, expanding telehealth services and supporting integrated, team-based care that includes physician assistants, nurse practitioners, medical assistants, community health workers and behavioral health specialists.